Arcosa, Inc. (ACA) Q1 2024 Earnings Call Transcript

May 03, 2024 11:38 AM ETArcosa, Inc. (ACA) StockACA
SA Transcripts
154.07K Followers

Q1: 2024-05-02 Earnings Summary

EPS of $0.73 beats by $0.21
 | Revenue of $598.60M (8.99% Y/Y) beats by $18.54M

Arcosa, Inc. (NYSE:ACA) Q1 2024 Earnings Conference Call April 3, 2024 8:30 AM ET

Company Participants

Erin Drabek - Director, IR
Antonio Carrillo - President and CEO
Gail Peck - CFO

Conference Call Participants

Ian Zaffino - Oppenheimer
Brent Thielman - D.A. Davidson
Garik Shmois - Loop Capital Markets
Trey Grooms - Stephens

Operator

Good morning, ladies and gentlemen, and welcome to the Arcosa, Inc. First Quarter 2024 Earnings Conference Call. My name is Jamie, and I will be your conference call coordinator today. As a reminder, today's call is being recorded.

I'd now like to turn the call over to your host, Erin Drabek , Director of Investor Relations for Arcosa. Ms. Drabek, you may begin.

Erin Drabek

Good morning, everyone, and thank you for joining Arcosa's first quarter 2024 earnings call. With me today are Antonio Carrillo, President and CEO; and Gail Peck, CFO. A question-and-answer session will follow their prepared remarks. A copy of yesterday's press release and the slide presentation for this morning's call are posted on our Investor Relations website, ir.arcosa.com. A replay of today's call will be available for the next 2 weeks. Instructions for accessing the replay number are included in the press release. A replay of the webcast will be available for 1 year on our website under the News and Events tab.

Today's comments and presentation slides contain financial measures that have not been prepared in accordance with GAAP. Reconciliations of non-GAAP financial measures to the closest GAAP measure are included in the appendix of the slide presentation. In addition, today's conference call contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. Please refer to the company's SEC filings for more

Recommended For You

About ACA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on ACA